Azacitidine (Q81862856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Azacitidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

ChEBI release 2020-05-28

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Hagop Kantarjian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

S6-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

Myelodysplastic syndromes.

13 January 2020

cites work

1 reference

Myelodysplastic syndromes

31 March 2020

1 reference

Gene silencing in cancer in association with promoter hypermethylation

31 March 2020

1 reference

Epigenetics in human disease and prospects for epigenetic therapy

31 March 2020

1 reference

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

31 March 2020

1 reference

Novel therapies for myelodysplastic syndromes

31 March 2020

1 reference

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

31 March 2020

1 reference

Efficacy of lenalidomide in myelodysplastic syndromes

31 March 2020

1 reference

DNA methylation patterns and epigenetic memory

31 March 2020

1 reference

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

31 March 2020

1 reference

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

31 March 2020

1 reference

Epigenetic targets in hematopoietic malignancies

31 March 2020

1 reference

5-azacytidine in acute leukemia

31 March 2020

1 reference

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1726

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962522%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference